SAPHIR: real-world clinical research platform for molecular testing, treatment, and clinical and patient-reported outcomes in patients with gastroesophageal cancer in Germany

Background: The treatment landscape of gastroesophageal cancer (GEC) is evolving. A better understanding of GEC biology and novel effective drugs would enhance the standard of care. To further improve outcomes for patients with GEC, it is crucial to evaluate treatment, response, survival, and patien...

Descripció completa

Dades bibliogràfiques

Autors principals:	K. Potthoff, T. Dechow, S. Lorenzen, A. Reinacher-Schick, A. Binninger, C. Matillon, H.-U. Siebenbach, I. Haffner, U. Hacker, H. Bläker, F. Lordick
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2023-12-01
Col·lecció:	ESMO Real World Data and Digital Oncology
Matèries:	early-/late-stage gastroesophageal cancer treatment clinical and patient-reported outcomes biomarker real-world data personalized medicine
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2949820123000073
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!